The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

Compared with usual care, a system of electronic provider notification more often enabled patients diagnosed with severe ...

The 24-month postprocedure risk of death or stroke was 13.7% in those who had delayed TAVI and who were diagnosed with acute valve syndrome at the time of aortic valve replacement (AVR) conversion. In ...

Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of measuring the ...

Background: Following transcatheter aortic valve replacement, acute coronary obstruction is infrequent but potentially life-threatening, while delayed coronary obstruction is even more uncommon. Case ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years, strong valve ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years ...

Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence ...

Perspective from Gilbert H.L. Tang, MD, MSc, MBA CHICAGO — The first trial to evaluate use of an SGLT2 inhibitor in people undergoing transcatheter aortic valve replacement showed benefit with ...

Patients enrolled at 28 U.S. sites between 2018 and 2024 with moderate-to-severe or severe symptomatic aortic regurgitation underwent TAVR with the JenaValve Trilogy transcatheter heart valve. Total ...

Valve durability and performance were also excellent in both groups. In the international Evolut Low Risk trial, investigators randomized 1,414 patients (mean age 74 years, 35% women) with severe ...